SARS-CoV-2 breakthrough infections among hospitalized patients in southeastern Michigan

Background: As of January 2022, more than 57 million cases of COVID-19 have been reported in the United States. Three primary COVID-19 vaccines are widely available: Pfizer (BNT162b2), Moderna (mRNA-1273), and Johnson & Johnson’s-Janssen (JNJ-78436735). The vaccines are effective but do not prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Fine, Sydney, Necaise, Kellee, Hayward, Alexandra, Malani, Anurag
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614960/
http://dx.doi.org/10.1017/ash.2022.133

Ejemplares similares

Ejemplares similares